ATG5 and amyotrophic lateral sclerosis: In conclusion, these changes suggest that the M1- and C7-TDP-43 PFFs-injected Atg5+/- mice exhibited ALS-like symptoms, including short survival, weight loss, abnormal gait, and motor dysfunction.